RxDoctor Payments Data

Amanda Bear, PA

Physician Assistant · Pensacola, FLNPI 1649529884

Payments from drug & device makers

$20,784in general payments, 2019–2025

Across 1,069 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lundbeck LLC$2K
  • Jazz Pharmaceuticals Inc.$2K
  • Novartis$1K
  • Pfizer$1K
  • Lilly USA, LLC$1K
  • plus $11K from 54 others

What the payments were for

  • Consulting fees$7954%
  • Speaking & faculty fees$880%
  • Food & beverage$19,74195%
  • Education$1611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)233$2,965
Lundbeck LLC29$1,612
Jazz Pharmaceuticals Inc.68$1,585
Novartis75$1,381
Pfizer112$1,284
Lilly USA, LLC34$1,228
SK Life Science, Inc.42$877
Eisai Inc.26$697
Genentech USA, Inc.27$526
Amgen(2 entities)29$525
Biogen35$524
Axsome Therapeutics, Inc.16$507
Teva Pharmaceuticals USA, Inc.26$500
Impel Pharmaceuticals Inc.30$495
UCB, Inc.27$452
Acorda Therapeutics, Inc20$396
AstraZeneca(2 entities)17$376
Argenx US, Inc.13$346
Biohaven Pharmaceuticals, Inc.7$326
Biohaven Pharmaceutical Holding Company Ltd.16$295
Acadia Pharmaceuticals Inc15$267
Otsuka America Pharmaceutical, Inc.12$261
Neurocrine Biosciences, Inc.11$231
Merz Pharmaceuticals, LLC8$208
MDD US Operations, LLC5$199
Grifols USA, LLC10$191
CSL Behring5$183
Octapharma USA, Inc.7$173
Takeda Pharmaceuticals U.S.A., Inc.10$166
EMD Serono, Inc.6$140
Mallinckrodt Hospital Products Inc.5$133
Merck8$121
Johnson & Johnson(2 entities)6$119
Sanofi6$116
Averitas Pharma Inc.6$104
Amneal Pharmaceuticals LLC5$90
Xeris Pharmaceuticals, Inc.5$84
Neurelis, Inc.4$79
Genentech, Inc.1$76
Alnylam Pharmaceuticals Inc.4$70
Tanabe Pharma America, Inc.4$67
Sunovion Pharmaceuticals Inc.6$64
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$62
GE HealthCare3$62
Arbor Pharmaceuticals, Inc.3$57
Adamas Pharmaceuticals, Inc.3$55
Bristol Myers Squibb2$48
Catalyst Pharmaceuticals, Inc.2$43
Medtronic2$42
E.r. Squibb & Sons, L.L.C.1$41
Inspire Medical Systems, Inc.2$40
Kyowa Kirin, Inc.2$40
Harmony Biosciences LLC3$34
Upsher-smith Laboratories LLC2$33
Greenwich Biosciences, Inc.2$33
Currax Pharmaceuticals LLC2$26
Livanova USA, Inc.1$23
Cala Health, Inc.1$20
Avanir Pharmaceuticals, Inc.1$15
Boston Scientific1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,784 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$46,840
Medicare patients
106
Services billed
5,303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuedextaDextromethorphan Hbr/Quinidine11$16,782
Nurtec OdtRimegepant Sulfate12$12,884
DilantinPhenytoin Sodium Extended12$3,781
Gabapentin41$1,319
Duloxetine Hcl16$575
Propranolol Hcl23$514
Memantine Hcl17$318
Tizanidine Hcl24$309
Donepezil Hcl29$302
Baclofen18$256
Carbidopa-LevodopaCarbidopa/Levodopa14$244
Topiramate26$218
Promethazine Hcl13$218
Pramipexole DihydrochloridePramipexole Di-Hcl11$191
Cyclobenzaprine Hcl11$184

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Avanir Pharmaceuticals, Inc.Nuedexta$15$16,78211 claims
PfizerNurtec Odt, Dilantin$1,284$16,66524 claims
Upsher-smith Laboratories LLCTopiramate$33$21826 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Pensacola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →